ANGELO SANTIAGO: Open Payments
NPI 1356069900 · IRVINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,388 in 116 payments from 15 companies in 2025. Trend: 2023 $2,190 · 2024 $1,882 · 2025 $2,388
Food & beverage: $2,388
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 44 | $735 |
| ABBVIE INC. | 19 | $320 |
| Teva Pharmaceuticals USA, Inc. | 17 | $284 |
| Neurocrine BioSciences, Inc. | 8 | $216 |
| Otsuka America Pharmaceutical, Inc. | 5 | $199 |
| Indivior Inc. | 4 | $118 |
| Alkermes, Inc. | 5 | $105 |
| Janssen Pharmaceuticals, Inc | 4 | $102 |
| ACADIA Pharmaceuticals Inc | 1 | $100 |
| Axsome Therapeutics, Inc. | 2 | $64 |
Products named: CAPLYTA, VRAYLAR, INGREZZA, UZEDY, REXULTI, SUBLOCADE, ARISTADA, INVEGA SUSTENNA.
Industry payments across CA — which companies pay providers there.
